SEARCH

SEARCH BY CITATION

References

  • Acosta-Rodriguez EA, Napolitani G, Lanzavecchia A & Sallusto F (2007) Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8: 942949.
  • Amlong CA, Nardelli DT, Heil Peterson S, Warner TF, Callister SM & Schell RF (2006) Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol 13: 289296.
  • Anguita J, Rincon M, Samanta S, Barthold SW, Flavell RA & Fikrig E (1998) Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis. J Infect Dis 178: 15121515.
  • Barthold SW (1996) Lyme borreliosis in the laboratory mouse. J Spirochet Tick-borne Dis 3: 2244.
  • Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL & Kuchroo VK (2006) Reciprocal development pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235238.
  • Briskin M, Kuwabara MD, Sigman DS & Wall R (1988) Induction of κ transcription by interferon-γ without activation of NF-κB. Science 242: 10361037.
  • Brown CR & Reiner SL (1999) Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect Immun 67: 33293333.
  • Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM & Schell RF (2003) Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 71: 34373442.
  • Callister SM, Jobe DA, Schell RF, Pavia CS & Lovrich SD (1996) Sensitivity and specificity of the Borreliacidal-Antibody Test during early Lyme disease: a “gold standard”? Clin Diagn Lab Immunol 3: 399402.
  • Christopherson JA, Munson EL, England DM, Croke CL, Remington MC, Molitor ML, DeCoster DJ, Callister SM & Schell RF (2003) Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha. Clin Diagn Lab Immunol 10: 4452.
  • Creson JR, Lim LC, Glowacki NJ, Callister SM & Schell RF (1996) Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent antibody assay performed by flow cytometry, and western immunoblotting. Clin Diagn Lab Immunol 3: 184190.
  • Croke CL, Munson EL, Lovrich SD, Christopherson JA, Remington MC, England DM, Callister SM & Schell RF (2000) Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun 68: 658663.
  • Ghiringhelli F, Ménard C, Terme M et al. (2005) CD4+CD25+ regulatory T cells inhibit natural killer cell function in a transforming growth factor-β-dependent manner. J Exp Med 202: 10751085.
  • Glickstein L, Edelstein M & Dong JZ (2001) Gamma interferon is not required for arthritis resistance in the murine Lyme disease model. Infect Immun 69: 37373743.
  • Gross DM, Steere AC & Huber BT (1998) T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 160: 10221028.
  • Heil Peterson S, Nardelli DT, Warner TF, Callister SM, Torrealba JR & Schell RF (2007) Anti-p19 antibody treatment exacerbates Lyme arthritis and enhances borreliacidal activity. Clin Vaccine Immunol 14: 510517.
  • Jensen JR, DuChateau BK, Munson EL, Callister SM & Schell RF (1998) Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi. Infect Immun 66: 15071512.
  • Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB & Fauci AS (1986) Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 137: 38553860.
  • Kehrl JH, Thevenin C, Rieckmann P & Fauci AS (1991) Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol 146: 40164023.
  • Keitel WA (1999) Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 28 Suppl 2), S118S123.
  • Kenefick KB, Lim LC, Alder JD, Schmitz JL, Czuprynski CJ & Schell RF (1993) Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi. J Infect Dis 167: 10861092.
  • Kohm AP, McMahon JS, Podojil JR, Smith Begolka W, DeGutes M, Kasprowicz DJ, Ziegler SF & Miller SD (2006) Cutting edge: anti-CD25 monoclonal antibody injection results in functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 176: 33013305.
  • Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, Strom TB, Oukka M & Kuchroo VK (2007) IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448: 484487.
  • Lee G, Ellingsworth LR, Gillis S, Wall R & Kincade PW (1987) β Transforming growth factors are potential regulators of B lymphopoiesis. J Exp Med 166: 12901299.
  • Lim LCL, England DM, DuChateau BK, Glowacki NJ, Creson JR, Lovrich SD, Callister SM, Jobe DA & Schell RF (1994) Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun 62: 28252833.
  • Loughry A, Fairchild S, Athanasou N, Edwards J & Hall FC (2005) Inflammatory arthritis and dermatitis in thymectomized, CD25+ cell-depleted mice. Rheumatology 44: 299308.
  • Lovrich SD, Callister SM, Lim LCL & Schell RF (1993) Seroprotective groups among isolates of Borrelia burgdorferi. Infect Immun 61: 43674374.
  • Marie J C, Letterio J J, Gavin M & Rudensky A Y (2005) TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201: 10611067.
  • McKisic MD, Redmond WL & Barthold SW (2000) Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol 164: 60966099.
  • Miller CL, Feldhaus AL, Rooney JW, Rhodes LD, Hopkins Sibley C & Singh H (1991) Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation. Mol Cell Biol 11: 48854894.
  • Morgan ME, Sutmuller RPM, Witteveen HJ, Van Duivenvoorde LM, Zanelli E, Melief CJM, Snijders A, Offringa R, De Vries RRP & Toes REM (2003) CD25+ T cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 48: 14521460.
  • Munson EL, Nardelli DT, Luk KHK, Remington MC, Callister SM & Schell RF (2006) Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro. Clin Vacc Immunol 13: 1925.
  • Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H & Strober W (2004) TGF-β1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172: 834842.
  • Nardelli DT, Burchill MA, England DM, Torrealba J, Callister SM & Schell RF (2004) Association of CD4+CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged interferon gamma-deficient mice treated with anti-interleukin-17 antibody. Clin Diagn Lab Immun 11: 10751084.
  • Nardelli DT, Callister SM & Schell RF (2008) Lyme anthritis: current concepts and a change in paradigm. Clin Vaccine Immunol 15: 2134.
  • Nardelli DT, Cloute JP, Luk KHK, Torrealba J, Warner TF, Callister SM & Schell RF (2005) CD4+CD25+ T cells prevent arthritis associated with Borrelia vaccination and infection. Clin Diagn Lab Immunol 12: 786792.
  • Nardelli DT, Warner TF, Callister SM & Schell RF (2006) Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production. Clin Vaccine Immunol 13: 884891.
  • Oida T, Xu L, Weiner HL, Kitani A & Strober W (2006) TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling. J Immunol 177: 23312339.
  • Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T & Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res 59: 31283133.
  • Schmitz JL, Schell RF, Hejka A, England DM & Konick L (1998) Induction of Lyme arthritis in LSH hamsters. Infect Immun 56: 23362342.
  • Schramm C, Huber S, Protschka M, Czochra P, Burg J, Schmitt E, Lohse AW, Galle PR & Blessing M (2004) TGF-β regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int Immunol 16: 12411249.
  • Steel RGD & Torrie JH (1960) Principles and Procedures of Statistics with Special Reference to the Biological Sciences, pp. 99276. McGraw-Hill Book Co., New York.
  • Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM & Stockinger B (2006) TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179189.
  • Yssel H, Shanafelt M-C, Sodoerberg C, Schneider PV, Anzola J & Peltz G (1991) Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 174: 593601.